A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants
Clinical trial NCT07046559 · RECRUITING
Trial details
- NCT number
- NCT07046559
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2027-09-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.